Patients treated at a hospital-at-home program had lower rates of mortality and emergency department use compared to patients cared for in brick-and-mortar hospitals, a new study found.
Here are seven things to know from a May 5 JAMA Network Open study by researchers at Iowa City-based University of Iowa. The authors analyzed data from nearly 16,000 Medicare patients at hospital-at-home approved hospitals between January 2021 and December 2022.
1. In-hospital mortality was 0.4% for hospital at home vs. 3.6% for traditional inpatient care, even though the patients’ risk profiles were similar.
2. Hospital-at-home patients had fewer ED visits within 30 days, while readmission rates were similar between the two models.
3. Patients treated at home had lower ICU escalation (3.5% vs. 7.9%) and fewer hospital-associated complications (3.6% vs. 5.1%).
4. About 95% of hospital-at-home patients were discharged home, compared to roughly 73% of inpatients.
5. Total 30-day spending was modestly lower, but index hospitalization costs were slightly higher, with savings driven by lower post-discharge costs.
6. Hospital-at-home patients had a modestly longer length of stay than those treated in hospitals.
7. Just 11 hospitals accounted for about half of all hospital-at-home admissions, with most programs concentrated in urban areas in the Northeast and South.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
